NPI: 1578057394 · MOORESVILLE, NC 28115 · Pediatrics Physician · NPI assigned 06/15/2018
Authorized official WALTON, LEEA controls 20+ related entities in our dataset. Read more
| Authorized Official | WALTON, LEEA (RCS MANAGER) |
| NPI Enumeration Date | 06/15/2018 |
Other providers sharing the same authorized official: WALTON, LEEA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 3,805 | $116K |
| 2019 | 13,527 | $591K |
| 2020 | 11,268 | $546K |
| 2021 | 24,548 | $849K |
| 2022 | 34,862 | $914K |
| 2023 | 30,537 | $572K |
| 2024 | 23,861 | $62K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 16,708 | 13,699 | $1.06M |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 9,330 | 8,060 | $865K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 5,529 | 4,410 | $271K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 5,869 | 4,969 | $259K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 3,172 | 2,557 | $203K |
| 99199 | Unlisted special service, procedure or report | 63,085 | 61,727 | $199K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 5,848 | 4,864 | $171K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1,619 | 1,284 | $152K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1,015 | 842 | $101K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 5,342 | 4,269 | $98K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 539 | 486 | $52K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 4,827 | 4,121 | $41K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3,462 | 2,915 | $32K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1,265 | 1,232 | $25K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 215 | 176 | $22K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1,223 | 1,177 | $17K |
| 87634 | 474 | 350 | $14K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1,000 | 494 | $14K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 356 | 352 | $11K |
| 87081 | 1,074 | 1,044 | $7K | |
| D0145 | Oral evaluation for a patient under three years of age | 161 | 123 | $6K |
| 99051 | 185 | 183 | $5K | |
| 90461 | 2,257 | 1,889 | $4K | |
| 96127 | 721 | 578 | $4K | |
| 90686 | 1,950 | 1,812 | $3K | |
| D1206 | Topical application of fluoride varnish | 161 | 123 | $3K |
| 96161 | 487 | 403 | $2K | |
| 90651 | 13 | 12 | $1K | |
| 81003 | 483 | 420 | $1K | |
| 0071A | 23 | 12 | $817.47 | |
| 36415 | Collection of venous blood by venipuncture | 118 | 101 | $306.43 |
| 90474 | 12 | 12 | $245.40 | |
| 99173 | 1,870 | 1,665 | $166.28 | |
| 96160 | 32 | 32 | $125.76 | |
| 92552 | 162 | 148 | $50.88 | |
| 99177 | 96 | 74 | $7.98 | |
| 90670 | 521 | 431 | $0.00 | |
| 90648 | 68 | 56 | $0.00 | |
| 90633 | 13 | 12 | $0.00 | |
| 36416 | 597 | 425 | $0.00 | |
| 90680 | 85 | 64 | $0.00 | |
| 90698 | 366 | 311 | $0.00 | |
| 90723 | 24 | 16 | $0.00 | |
| 92551 | 28 | 26 | $0.00 | |
| 91307 | 23 | 12 | $0.00 |